MOLECULAR AND CELLULAR PROBES-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2190768, encodeId=5e522190e6810, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基础研究 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae266449765, createdName=ms5000002028165215, createdTime=Sun Mar 03 13:48:20 CST 2024, time=2024-03-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2132615, encodeId=603921326159c, content=最近投稿秒拒率非常之高呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6a41662689, createdName=chinameng, createdTime=Fri May 12 09:08:03 CST 2023, time=2023-05-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2099273, encodeId=f37820992e3d4, content=reviewer invited要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ace25692978, createdName=ms8000000551179908, createdTime=Tue Nov 08 22:08:33 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907798, encodeId=e7e190e79872, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：微生物 经验分享：审稿快，不收版面费，除了分数低，别的都很完美。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18e94877178, createdName=zhangjingyun, createdTime=Mon Dec 14 11:29:47 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119027, encodeId=3c40211902e34, content=偏重的研究方向：细胞免疫 经验分享：大家proof时间需要多久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbc25508529, createdName=Ddffffg, createdTime=Sun Mar 12 08:05:29 CST 2023, time=2023-03-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1248234, encodeId=c12d1248234f1, content=投稿链接不见，请有知道投稿链接的吗？？先谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a761562476, createdName=awangling, createdTime=Fri Sep 09 23:30:06 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006428, encodeId=fd1c10064288d, content=投了10天了，怎么稿号都还没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb6f5518840, createdName=ms2000000622008027, createdTime=Mon Aug 09 19:42:26 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095138, encodeId=1f1d109513850, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095137, encodeId=5f81109513e29, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541157, encodeId=1a6154115e79, content=有点惨淡，这1.5分都保不住，日子怎么过？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yumi_123, createdTime=Fri Jul 14 18:45:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2024-03-03 ms5000002028165215 来自湖北省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：基础研究
经验分享：无

9 0

[GetPortalCommentsPageByObjectIdResponse(id=2190768, encodeId=5e522190e6810, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基础研究 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae266449765, createdName=ms5000002028165215, createdTime=Sun Mar 03 13:48:20 CST 2024, time=2024-03-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2132615, encodeId=603921326159c, content=最近投稿秒拒率非常之高呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6a41662689, createdName=chinameng, createdTime=Fri May 12 09:08:03 CST 2023, time=2023-05-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2099273, encodeId=f37820992e3d4, content=reviewer invited要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ace25692978, createdName=ms8000000551179908, createdTime=Tue Nov 08 22:08:33 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907798, encodeId=e7e190e79872, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：微生物 经验分享：审稿快，不收版面费，除了分数低，别的都很完美。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18e94877178, createdName=zhangjingyun, createdTime=Mon Dec 14 11:29:47 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119027, encodeId=3c40211902e34, content=偏重的研究方向：细胞免疫 经验分享：大家proof时间需要多久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbc25508529, createdName=Ddffffg, createdTime=Sun Mar 12 08:05:29 CST 2023, time=2023-03-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1248234, encodeId=c12d1248234f1, content=投稿链接不见，请有知道投稿链接的吗？？先谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a761562476, createdName=awangling, createdTime=Fri Sep 09 23:30:06 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006428, encodeId=fd1c10064288d, content=投了10天了，怎么稿号都还没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb6f5518840, createdName=ms2000000622008027, createdTime=Mon Aug 09 19:42:26 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095138, encodeId=1f1d109513850, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095137, encodeId=5f81109513e29, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541157, encodeId=1a6154115e79, content=有点惨淡，这1.5分都保不住，日子怎么过？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yumi_123, createdTime=Fri Jul 14 18:45:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2023-05-12 chinameng 来自山东省

最近投稿秒拒率非常之高呀

25 0

[GetPortalCommentsPageByObjectIdResponse(id=2190768, encodeId=5e522190e6810, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基础研究 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae266449765, createdName=ms5000002028165215, createdTime=Sun Mar 03 13:48:20 CST 2024, time=2024-03-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2132615, encodeId=603921326159c, content=最近投稿秒拒率非常之高呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6a41662689, createdName=chinameng, createdTime=Fri May 12 09:08:03 CST 2023, time=2023-05-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2099273, encodeId=f37820992e3d4, content=reviewer invited要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ace25692978, createdName=ms8000000551179908, createdTime=Tue Nov 08 22:08:33 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907798, encodeId=e7e190e79872, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：微生物 经验分享：审稿快，不收版面费，除了分数低，别的都很完美。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18e94877178, createdName=zhangjingyun, createdTime=Mon Dec 14 11:29:47 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119027, encodeId=3c40211902e34, content=偏重的研究方向：细胞免疫 经验分享：大家proof时间需要多久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbc25508529, createdName=Ddffffg, createdTime=Sun Mar 12 08:05:29 CST 2023, time=2023-03-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1248234, encodeId=c12d1248234f1, content=投稿链接不见，请有知道投稿链接的吗？？先谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a761562476, createdName=awangling, createdTime=Fri Sep 09 23:30:06 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006428, encodeId=fd1c10064288d, content=投了10天了，怎么稿号都还没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb6f5518840, createdName=ms2000000622008027, createdTime=Mon Aug 09 19:42:26 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095138, encodeId=1f1d109513850, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095137, encodeId=5f81109513e29, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541157, encodeId=1a6154115e79, content=有点惨淡，这1.5分都保不住，日子怎么过？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yumi_123, createdTime=Fri Jul 14 18:45:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2022-11-08 ms8000000551179908

reviewer invited要持续多久啊？

128 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2190768, encodeId=5e522190e6810, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基础研究 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae266449765, createdName=ms5000002028165215, createdTime=Sun Mar 03 13:48:20 CST 2024, time=2024-03-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2132615, encodeId=603921326159c, content=最近投稿秒拒率非常之高呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6a41662689, createdName=chinameng, createdTime=Fri May 12 09:08:03 CST 2023, time=2023-05-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2099273, encodeId=f37820992e3d4, content=reviewer invited要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ace25692978, createdName=ms8000000551179908, createdTime=Tue Nov 08 22:08:33 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907798, encodeId=e7e190e79872, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：微生物 经验分享：审稿快，不收版面费，除了分数低，别的都很完美。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18e94877178, createdName=zhangjingyun, createdTime=Mon Dec 14 11:29:47 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119027, encodeId=3c40211902e34, content=偏重的研究方向：细胞免疫 经验分享：大家proof时间需要多久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbc25508529, createdName=Ddffffg, createdTime=Sun Mar 12 08:05:29 CST 2023, time=2023-03-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1248234, encodeId=c12d1248234f1, content=投稿链接不见，请有知道投稿链接的吗？？先谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a761562476, createdName=awangling, createdTime=Fri Sep 09 23:30:06 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006428, encodeId=fd1c10064288d, content=投了10天了，怎么稿号都还没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb6f5518840, createdName=ms2000000622008027, createdTime=Mon Aug 09 19:42:26 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095138, encodeId=1f1d109513850, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095137, encodeId=5f81109513e29, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541157, encodeId=1a6154115e79, content=有点惨淡，这1.5分都保不住，日子怎么过？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yumi_123, createdTime=Fri Jul 14 18:45:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2020-12-14 zhangjingyun

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：微生物
经验分享：审稿快，不收版面费，除了分数低，别的都很完美。

96 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2190768, encodeId=5e522190e6810, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基础研究 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae266449765, createdName=ms5000002028165215, createdTime=Sun Mar 03 13:48:20 CST 2024, time=2024-03-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2132615, encodeId=603921326159c, content=最近投稿秒拒率非常之高呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6a41662689, createdName=chinameng, createdTime=Fri May 12 09:08:03 CST 2023, time=2023-05-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2099273, encodeId=f37820992e3d4, content=reviewer invited要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ace25692978, createdName=ms8000000551179908, createdTime=Tue Nov 08 22:08:33 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907798, encodeId=e7e190e79872, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：微生物 经验分享：审稿快，不收版面费，除了分数低，别的都很完美。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18e94877178, createdName=zhangjingyun, createdTime=Mon Dec 14 11:29:47 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119027, encodeId=3c40211902e34, content=偏重的研究方向：细胞免疫 经验分享：大家proof时间需要多久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbc25508529, createdName=Ddffffg, createdTime=Sun Mar 12 08:05:29 CST 2023, time=2023-03-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1248234, encodeId=c12d1248234f1, content=投稿链接不见，请有知道投稿链接的吗？？先谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a761562476, createdName=awangling, createdTime=Fri Sep 09 23:30:06 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006428, encodeId=fd1c10064288d, content=投了10天了，怎么稿号都还没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb6f5518840, createdName=ms2000000622008027, createdTime=Mon Aug 09 19:42:26 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095138, encodeId=1f1d109513850, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095137, encodeId=5f81109513e29, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541157, encodeId=1a6154115e79, content=有点惨淡，这1.5分都保不住，日子怎么过？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yumi_123, createdTime=Fri Jul 14 18:45:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2023-03-12 Ddffffg 来自上海

偏重的研究方向：细胞免疫
经验分享：大家proof时间需要多久啊

28 0

[GetPortalCommentsPageByObjectIdResponse(id=2190768, encodeId=5e522190e6810, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基础研究 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae266449765, createdName=ms5000002028165215, createdTime=Sun Mar 03 13:48:20 CST 2024, time=2024-03-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2132615, encodeId=603921326159c, content=最近投稿秒拒率非常之高呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6a41662689, createdName=chinameng, createdTime=Fri May 12 09:08:03 CST 2023, time=2023-05-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2099273, encodeId=f37820992e3d4, content=reviewer invited要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ace25692978, createdName=ms8000000551179908, createdTime=Tue Nov 08 22:08:33 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907798, encodeId=e7e190e79872, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：微生物 经验分享：审稿快，不收版面费，除了分数低，别的都很完美。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18e94877178, createdName=zhangjingyun, createdTime=Mon Dec 14 11:29:47 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119027, encodeId=3c40211902e34, content=偏重的研究方向：细胞免疫 经验分享：大家proof时间需要多久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbc25508529, createdName=Ddffffg, createdTime=Sun Mar 12 08:05:29 CST 2023, time=2023-03-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1248234, encodeId=c12d1248234f1, content=投稿链接不见，请有知道投稿链接的吗？？先谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a761562476, createdName=awangling, createdTime=Fri Sep 09 23:30:06 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006428, encodeId=fd1c10064288d, content=投了10天了，怎么稿号都还没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb6f5518840, createdName=ms2000000622008027, createdTime=Mon Aug 09 19:42:26 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095138, encodeId=1f1d109513850, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095137, encodeId=5f81109513e29, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541157, encodeId=1a6154115e79, content=有点惨淡，这1.5分都保不住，日子怎么过？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yumi_123, createdTime=Fri Jul 14 18:45:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2022-09-09 awangling

投稿链接不见，请有知道投稿链接的吗？？先谢了

38 0

[GetPortalCommentsPageByObjectIdResponse(id=2190768, encodeId=5e522190e6810, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基础研究 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae266449765, createdName=ms5000002028165215, createdTime=Sun Mar 03 13:48:20 CST 2024, time=2024-03-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2132615, encodeId=603921326159c, content=最近投稿秒拒率非常之高呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6a41662689, createdName=chinameng, createdTime=Fri May 12 09:08:03 CST 2023, time=2023-05-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2099273, encodeId=f37820992e3d4, content=reviewer invited要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ace25692978, createdName=ms8000000551179908, createdTime=Tue Nov 08 22:08:33 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907798, encodeId=e7e190e79872, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：微生物 经验分享：审稿快，不收版面费，除了分数低，别的都很完美。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18e94877178, createdName=zhangjingyun, createdTime=Mon Dec 14 11:29:47 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119027, encodeId=3c40211902e34, content=偏重的研究方向：细胞免疫 经验分享：大家proof时间需要多久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbc25508529, createdName=Ddffffg, createdTime=Sun Mar 12 08:05:29 CST 2023, time=2023-03-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1248234, encodeId=c12d1248234f1, content=投稿链接不见，请有知道投稿链接的吗？？先谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a761562476, createdName=awangling, createdTime=Fri Sep 09 23:30:06 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006428, encodeId=fd1c10064288d, content=投了10天了，怎么稿号都还没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb6f5518840, createdName=ms2000000622008027, createdTime=Mon Aug 09 19:42:26 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095138, encodeId=1f1d109513850, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095137, encodeId=5f81109513e29, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541157, encodeId=1a6154115e79, content=有点惨淡，这1.5分都保不住，日子怎么过？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yumi_123, createdTime=Fri Jul 14 18:45:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2021-08-09 ms2000000622008027

投了10天了，怎么稿号都还没有

61 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2190768, encodeId=5e522190e6810, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基础研究 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae266449765, createdName=ms5000002028165215, createdTime=Sun Mar 03 13:48:20 CST 2024, time=2024-03-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2132615, encodeId=603921326159c, content=最近投稿秒拒率非常之高呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6a41662689, createdName=chinameng, createdTime=Fri May 12 09:08:03 CST 2023, time=2023-05-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2099273, encodeId=f37820992e3d4, content=reviewer invited要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ace25692978, createdName=ms8000000551179908, createdTime=Tue Nov 08 22:08:33 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907798, encodeId=e7e190e79872, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：微生物 经验分享：审稿快，不收版面费，除了分数低，别的都很完美。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18e94877178, createdName=zhangjingyun, createdTime=Mon Dec 14 11:29:47 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119027, encodeId=3c40211902e34, content=偏重的研究方向：细胞免疫 经验分享：大家proof时间需要多久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbc25508529, createdName=Ddffffg, createdTime=Sun Mar 12 08:05:29 CST 2023, time=2023-03-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1248234, encodeId=c12d1248234f1, content=投稿链接不见，请有知道投稿链接的吗？？先谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a761562476, createdName=awangling, createdTime=Fri Sep 09 23:30:06 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006428, encodeId=fd1c10064288d, content=投了10天了，怎么稿号都还没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb6f5518840, createdName=ms2000000622008027, createdTime=Mon Aug 09 19:42:26 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095138, encodeId=1f1d109513850, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095137, encodeId=5f81109513e29, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541157, encodeId=1a6154115e79, content=有点惨淡，这1.5分都保不住，日子怎么过？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yumi_123, createdTime=Fri Jul 14 18:45:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2021-12-28 小动量

什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？

46 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2190768, encodeId=5e522190e6810, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基础研究 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae266449765, createdName=ms5000002028165215, createdTime=Sun Mar 03 13:48:20 CST 2024, time=2024-03-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2132615, encodeId=603921326159c, content=最近投稿秒拒率非常之高呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6a41662689, createdName=chinameng, createdTime=Fri May 12 09:08:03 CST 2023, time=2023-05-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2099273, encodeId=f37820992e3d4, content=reviewer invited要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ace25692978, createdName=ms8000000551179908, createdTime=Tue Nov 08 22:08:33 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907798, encodeId=e7e190e79872, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：微生物 经验分享：审稿快，不收版面费，除了分数低，别的都很完美。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18e94877178, createdName=zhangjingyun, createdTime=Mon Dec 14 11:29:47 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119027, encodeId=3c40211902e34, content=偏重的研究方向：细胞免疫 经验分享：大家proof时间需要多久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbc25508529, createdName=Ddffffg, createdTime=Sun Mar 12 08:05:29 CST 2023, time=2023-03-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1248234, encodeId=c12d1248234f1, content=投稿链接不见，请有知道投稿链接的吗？？先谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a761562476, createdName=awangling, createdTime=Fri Sep 09 23:30:06 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006428, encodeId=fd1c10064288d, content=投了10天了，怎么稿号都还没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb6f5518840, createdName=ms2000000622008027, createdTime=Mon Aug 09 19:42:26 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095138, encodeId=1f1d109513850, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095137, encodeId=5f81109513e29, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541157, encodeId=1a6154115e79, content=有点惨淡，这1.5分都保不住，日子怎么过？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yumi_123, createdTime=Fri Jul 14 18:45:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2021-12-27 msSSSSSD

期刊发送的信件里需要注意几个方面的内容？

41 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2190768, encodeId=5e522190e6810, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基础研究 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae266449765, createdName=ms5000002028165215, createdTime=Sun Mar 03 13:48:20 CST 2024, time=2024-03-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2132615, encodeId=603921326159c, content=最近投稿秒拒率非常之高呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6a41662689, createdName=chinameng, createdTime=Fri May 12 09:08:03 CST 2023, time=2023-05-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2099273, encodeId=f37820992e3d4, content=reviewer invited要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ace25692978, createdName=ms8000000551179908, createdTime=Tue Nov 08 22:08:33 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907798, encodeId=e7e190e79872, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：微生物 经验分享：审稿快，不收版面费，除了分数低，别的都很完美。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18e94877178, createdName=zhangjingyun, createdTime=Mon Dec 14 11:29:47 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119027, encodeId=3c40211902e34, content=偏重的研究方向：细胞免疫 经验分享：大家proof时间需要多久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbc25508529, createdName=Ddffffg, createdTime=Sun Mar 12 08:05:29 CST 2023, time=2023-03-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1248234, encodeId=c12d1248234f1, content=投稿链接不见，请有知道投稿链接的吗？？先谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a761562476, createdName=awangling, createdTime=Fri Sep 09 23:30:06 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006428, encodeId=fd1c10064288d, content=投了10天了，怎么稿号都还没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb6f5518840, createdName=ms2000000622008027, createdTime=Mon Aug 09 19:42:26 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095138, encodeId=1f1d109513850, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095137, encodeId=5f81109513e29, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541157, encodeId=1a6154115e79, content=有点惨淡，这1.5分都保不住，日子怎么过？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yumi_123, createdTime=Fri Jul 14 18:45:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2017-07-14 yumi_123

有点惨淡，这1.5分都保不住，日子怎么过？？

399 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务